Proscia  

Philadelphia,  PA 
United States
http://www.proscia.com

• Booth: 718

Welcome to Proscia's Concentriq® digital pathology platform!

Proscia is a software company that is accelerating pathology’s digital transformation to change the way we understand diseases like cancer. Its Concentriq® digital pathology platform and powerful AI applications are advancing the 150-year old standard of research and diagnosis towards a data-driven discipline, unlocking new insights that accelerate discovery, improve patient outcomes, and fulfill the promise of precision care. Leading diagnostic laboratories and over 10 of the top 20 pharmaceutical companies rely on Proscia’s software each day. For more information, visit proscia.com. 

 Press Releases

• Proscia and Siemens Healthineers Ink Agreement to Expand Global Reach of Digital Pathology (Mar 17, 2022)
  https://proscia.com/press-releases/proscia-and-siemens-healthineers-ink-agreement-to-expand-global-reach-of-digital-pathology/
   

  Siemens Healthineers expands its Enterprise Imaging offering with Proscia’s Concentriq Dx platform for digital pathology

  PHILADELPHIA–(BUSINESS WIRE)– Proscia®, the leader in digital and computational pathology solutions, today announced a multi-year OEM agreement with Siemens Healthineers. Under the agreement, Siemens Healthineers will expand its Enterprise Imaging offering towards the global digital pathology market using Proscia’s Concentriq® Dx platform.

  The partnership comes amid a tipping point for the digital pathology market. Demand for digital pathology has surged as systemic challenges long threatening the traditional laboratory model centered around pathologists and microscopes in physical spaces have intensified in the pandemic and post-pandemic era. Mounting pressures created by a shrinking pathologist population, rising biopsy volume, and industry consolidation have been exacerbated by the pandemic-driven shift to remote work. Laboratories are now rapidly seeking to modernize their pathology operations, but legacy software systems lack the necessary enterprise-wide capabilities, preventing labs from achieving true digitization.

  With Proscia’s Concentriq Dx platform, Siemens Healthineers is entering the digital pathology market to satiate the rampant demand and expand its Enterprise Imaging offering with industry-leading technology to realize the full value of digital pathology operations. Siemens Healthineers is a global leader in healthcare IT, with solutions that span nearly all major departments and disease states at the world’s leading health systems. The agreement with Proscia enables Siemens Healthineers to expand into one of the few remaining areas of healthcare that has just started to experience the full benefits of digitization.

  Siemens Healthineers selected Proscia after conducting an extensive evaluation process. Several key aspects of Proscia’s technology that Siemens Healthineers cited in its decision include product maturity, superior end-user experience, open platform, future-proof capabilities, and recognized brand with in-depth domain knowledge. Siemens Healthineers’ Syngo Carbon Enterprise Imaging Solution offers a wide range of possibilities with image interpretation, reporting, AI implementation, data management, archiving and migration, including unique access to innovation platforms through seamless integration.

  “Healthcare’s rapid digital transformation has emphasized the value of data in reshaping the way clinicians and researchers understand, diagnose, and fight disease,” said Christian Zapf, Head of Imaging Software & IT at Siemens Healthineers. “The traditional practice of pathology is on the verge of the biggest transformation the field has seen since the introduction of light microscopy, and we’re excited to accelerate pathology’s digital transformation and pioneer breakthroughs with a strong partner complementing our core strength in enterprise reading and reporting resulting in higher efficiency and improved patient outcomes.”

  Proscia’s Concentriq Dx in combination with Syngo Carbon offers a best-of-breed solution for digitizing pathology operations at scale alongside diagnostic radiology imaging for healthcare enterprises. By entering the rapidly growing digital pathology market with Concentriq, Siemens Healthineers is expanding its position as one of the industry leaders in healthcare with solutions covering the entire clinical pathway, providing a full spectrum of enterprise services across digital, data, and AI.

  “Our partnership with Siemens Healthineers represents a seminal moment for Proscia and a monumental leap for digital pathology on a global scale,” said David West, CEO of Proscia. “We’re honored to work together with the worldwide leader in medical imaging to accelerate pathology’s digital transformation, improve the quality of care with more precise and personalized diagnoses, and ensure improved patient outcomes.”

  Proscia’s Concentriq is a singular, scalable platform that enables laboratory networks to unify pathology operations and eliminate the geographic silos to realize a truly connected and collaborative global practice. The platform sits at the lab’s center of gravity, connecting a diverse ecosystem of hardware and software into a single solution. Concentriq’s pathologist-centric design was developed by and for pathologists to deliver an interface that feels natural, is highly responsive, supports real-time collaboration for consults and second opinions, and makes digital image viewing as smooth as possible. The platform’s future-proof design is ready now for pathology’s computationally driven future, with an integration layer capable of supporting plug-and-play adoption of AI applications.

  About Proscia
  Proscia is a software company that is accelerating pathology’s digital transformation to change the way we understand diseases like cancer. Its Concentriq digital pathology platform and powerful AI applications are advancing the 150-year-old standard of research and diagnosis towards a data-driven discipline, unlocking new insights that accelerate discovery, improve patient outcomes, and fulfill the promise of precision care. Leading diagnostic laboratories and over 10 of the top 20 pharmaceutical companies rely on Proscia’s software each day. For more information, visit proscia.com.

  Contacts

  Matt Robbins
  Matter Health for Proscia
  proscia@matternow.com

• Proscia and Hamamatsu Announce Collaboration to Accelerate Scaled Adoption of Digital Pathology (Mar 17, 2022)

  https://proscia.com/press-releases/proscia-and-hamamatsu-announce-collaboration-to-accelerate-scaled-adoption-of-digital-pathology/

  Cooperation agreement expands access to unified solution for end-to-end workflow

  PHILADELPHIA – March 9, 2022 – Proscia®, the leader in digital and computational pathology solutions, and Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, today announced a collaboration to accelerate digital pathology adoption at an enterprise scale. The cooperation agreement increases availability of the companies’ best-of-breed, unified solution that combines Proscia’s Concentriq® platform and Hamamatsu’s NanoZoomer® series of whole slide scanners to deliver the full promise of pathology’s digital transformation to laboratories.

  Digital pathology adoption requires laboratories to leverage a diverse and complex ecosystem of hardware and software solutions that play a vital role in pathologists’ workflows. To practice digital pathology at scale and optimize the end-to-end workflow, laboratories are recognizing the need for an open approach focused on broad interoperability to centralize critical data and routine operations. By employing such an approach, laboratories can drive efficiency and obtain a more holistic view of patients, while equipping pathologists with the flexible, adaptable tools needed to meet the clinical and operational needs of both today and tomorrow.

  The collaboration expands access to the companies’ existing joint solution for scanning, image management, and AI, building upon its market traction to-date. Together, Hamamatsu’s NanoZoomer scanners and Proscia’s AI-enabled Concentriq platform for image and data management provide a unified solution for the end-to-end pathology workflow, delivering seamless interoperability and enhanced customer experience. Users of Hamamatsu’s scanners can now seamlessly integrate their images and all other data into an open ecosystem centered around Concentriq, enabling leading laboratories to drive day-to-day operations and practice digital pathology at enterprise scale. Under the cooperation agreement, customers will also receive support with implementation to derive full value from the joint solution.

  “This collaboration between Hamamatsu and Proscia will provide a true open ecosystem to the market to increase digital pathology adoption,” said Akiyoshi Mabuchi, Manager Business Planning, Systems Division at Hamamatsu.

  A unified image and data management platform, Proscia’s Concentriq provides leading laboratories and research institutions with a robust, end-to-end solution that also serves as a launchpad for AI applications developed by Proscia, Proscia’s customers, and other third parties. The flagship software is used by leading laboratories and health systems, as well as 10 of the top 20 pharmaceutical companies, for routine image viewing, management, and analysis at an enterprise scale. With Concentriq, laboratories can tap into the interoperability and scalability required to achieve streamlined, reliable operations for pathologists and enhanced outcomes for patients.

  “Our Concentriq platform is designed to serve as the center of all digital pathology operations, and we are thrilled to be collaborating with Hamamatsu to synergize our efforts in scaling digitization,” said David West, CEO, Proscia. “Our collaboration will strengthen our mutual vision to accelerate digital pathology adoption and pioneer a new era of diagnostics.”

  About Proscia

  Proscia is a software company that is accelerating pathology’s digital transformation to change the way we understand diseases like cancer. Its Concentriq digital pathology platform and powerful AI applications are advancing the 150-year-old standard of research and diagnosis towards a data-driven discipline, unlocking new insights that accelerate discovery, improve patient outcomes, and fulfill the promise of precision care. Leading diagnostic laboratories and over 10 of the top 20 pharmaceutical companies rely on Proscia’s software each day. For more information, visit www.proscia.com.

  About Hamamatsu

  Hamamatsu Photonics K.K. is a leading manufacturer of photonics devices. We design, manufacture, and sell optical sensors, light sources, optical components, cameras, photometry systems, and measurement/analysis systems. For more information, visit www.nanozoomer.com.

 Products